MIODx
Alain Mir is the Chief Scientific Officer at MIODx.
This person is not in any offices
MIODx
MIODx® is using its custom ClonoMap platform to profile an individual’s adaptive immune system over time. The ultimate goal is to use T cell diversity as a prognostic tool to improve medical outcomes.